Heidelberg Pharma AG (ETR:HPHA) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 11/03/2025 at 10:12, 3 months 4 days ago

Heidelberg Pharma Reveals Promising Data for HDP-101 at ADC Congress 2025

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC Congress
PRESS RELEASE

published on 11/03/2025 at 10:07, 3 months 4 days ago

Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar
Heidelberg Pharma to present new clinical data of lead ADC candidate HDP-101 at the World ADC Congress 2025 and host a webinar. Study results show promising anti-tumor activity in multiple myeloma patients

Webinar Clinical Data Heidelberg Pharma Multiple Myeloma ADC Candidate
BRIEF

published on 10/23/2025 at 08:02, 3 months 15 days ago

Heidelberg Pharma's HDP-101 Receives Fast Track Designation from FDA

FDA Heidelberg Pharma HDP-101 Multiple Myeloma Fast Track Designation
PRESS RELEASE

published on 10/23/2025 at 07:57, 3 months 15 days ago

Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
Heidelberg Pharma's lead ADC candidate HDP-101 granted Fast Track Designation by US FDA for the treatment of multiple myeloma. Accelerated review for innovative cancer therapy

Heidelberg Pharma Multiple Myeloma Fast Track Designation ADC Candidate US FDA
BRIEF

published on 10/09/2025 at 07:08, 3 months 29 days ago

Heidelberg Pharma's Nine-Month Update for 2025

Financial Results Clinical Trials Heidelberg Pharma HDP-101 Strategy Adjustment
PRESS RELEASE

published on 10/09/2025 at 07:03, 3 months 29 days ago

Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025
Heidelberg Pharma AG reports operational progress and financial figures for the first nine months of fiscal year 2025, focusing on lead ADC candidate HDP-101 and cost-saving measures

Financial Report Clinical Trial Cost-saving Measures Heidelberg Pharma AG ADC Candidate
BRIEF

published on 10/06/2025 at 16:03, 4 months 1 day ago

Heidelberg Pharma AG Revises Financial Guidance for 2025

Financial Guidance Heidelberg Pharma ADCs Operating Expenses Cash Requirements
PRESS RELEASE

published on 10/06/2025 at 15:58, 4 months 1 day ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its financial guidance for 2025, focusing on cost-saving measures. Sales, operating expenses, and cash requirements revised

Sales Financial Guidance Cost-saving Measures Heidelberg Pharma AG Operating Expenses
BRIEF

published on 09/25/2025 at 13:22, 4 months 12 days ago

Heidelberg Pharma Advances HDP-101 in Clinical Trial for Multiple Myeloma

HDP-101 Multiple Myeloma Safety Profile Phase I/IIa Trial Clinical Activity
PRESS RELEASE

published on 09/25/2025 at 13:17, 4 months 12 days ago

Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma
Heidelberg Pharma advances to Cohort 9 in Phase I/IIa trial of lead ATAC candidate HDP-101 in multiple myeloma, demonstrating favorable safety profile and early signs of clinical activity

Heidelberg Pharma Multiple Myeloma ATAC Candidate Phase I/IIa Trial Clinical Activity

Accesswire

Published on 02/07/2026 at 01:00, 1 day 2 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 4 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 5 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 12 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 14 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 6 hours 41 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 11 hours 6 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 11 hours 21 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 8 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 9 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 9 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 11 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 8 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 9 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 9 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE